Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jonathan Zager 🇺🇸 Moffit Cancer Center Presenting on Melanoma Staging and Molecular Testing
Presentation reviews current AJCC staging system for melanoma, outline present state of staging practices, and explore potential areas for refinement
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Øyvind Bruland 🇳🇴 Oslo
Alpha-emitting Radionuclide-Therapy with Bio-degradable microparticles injected intra-peritoneally
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Markus Mille 🇩🇪
Discussing: Robotic Single Port SP Surgery
Robotic single-port (SP) surgery, enabled by the da Vinci SP system, represents an advanced evolution in robotic-assisted surgery
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Anders Thornell 🇸🇪 Sahlgrenska
Mock Debate: Should follow-up for operated GIST tumors be escalated or de-escalated?
Two experts go head-to-head over early relapse detection, second cancer risk, scan burden, and guideline evolution.
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Laura Lorenzon 🇮🇹
Investigation and Management of GI Symptoms After Surgery
This presentation highlights the main dimensions related to quality of life, the main metrics used to measure symptoms and the main issues in this field
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Stefan Stättner 🇦🇹
Discussing Robotic Liver Surgery
Robotic liver surgery is moving from the acceptance to the standardization phase with emerging experience and higher availability of robotic systems.
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Wim Ceelen 🇧🇪 Ghent
Physically Enhanced IP Drug Delivery
Tumor tissue penetration is very limited after intraperitoneal drug delivery, hampering its clinical efficacy. I discuss how physical methods overcome transport barriers.
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Elinor Bexe Lindskog 🇸🇪
The Immune Microenvironment in Peritoneal Metastases
The immune landscape of peritoneal metastases differs from other metastatic sites. Peritoneal lesions show a fibro-inflammatory, immune-regulated niche
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Lasma Nikolaisone 🇱🇻
The Testimonial of a Young Rectal Cancer Patient
Rectal cancer treatment saves lives — but what follows is often a silent struggle with side effects that few discuss openly #RectalCancer
The OncoAlert Breast Cancer Faculty, led by Dr. Elisa Agostinetto🇧🇪 , has selected the OncoAlert🚨 TOP 🔟 #BreastCancer Abstracts to be presented at #ESMO25 in Berlin
See you in Berlin for #ESMO25!
The OncoAlert AF is ready to bring you all the great science coming out of Germany🇩🇪 .
We encourage you to follow these outstanding colleagues, and—as always—OncoAlert will be on the ground reporting in real time on all the latest news and trials.
A warm welcome to the 43rd Annual CFS, NOW VIRTUAL (LIVE OR ONLINE) !!
HCP's Register FOR FREE 👉 (USE CODE: ONCOALERT ) tinyurl.com/3ak6zm6s
A great 3 day conference for health care professionals focused on evidence-based, state-of-the-art cancer care. SIGN UP FOR FREE VIRTUAL REGISTRATION!
NEWS FROM INDUSTRY: UPDATE ON TROPION-Breast02 #BreastCancer
Source European Pharmaceutical Review, Astrazeneca, Daiichi Sankyo
www.europeanpharmaceuticalreview.com/news/266702/...
The phase III TROPION-Breast02 trial showed that the ADC Datopotamab Deruxtecandlnk significantly improved OS & PFS
Efficacy and safety of systemic therapies following progression on CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: a systematic review and network meta-analysis
www.sciencedirect.com/science/arti...
The OncoAlert #GUCancer Faculty, led by Dr. Natalia Gandur🇦🇷 , Dr. Regina Barragan🇲🇽 & Dr. Gil Morgan🇺🇸 have selected the OncoAlert TOP🔟 #ESMO25 Abstracts In #ProstateCancer, #KidneyCancer #BladderCancer and #PenisCancer to be presented in Berlin🇩🇪 Picked using a Delphi System to establish our picks.
Oncology Here & NOW S2E3 in #BreastCancer
with @elisaagostinetto.bsky.social & @erikahamilton9.bsky.social discussing:
✅Current & emerging treatments
✅Patient selection
✅T-DXd + pertuzumab
✅ILD management & more
@hoperugo.bsky.social @elisabettabonzano.bsky.social
youtu.be/YdUX52c22Ig
A Great Day One of #IUCS25 Great Presentation by Dr. Partha Choudhury
The Theranostic Revolution
✨ Early randomized results look promising
🎯 Time to reimagine dosimetry & radionuclide choice for optimized delivery
#ProstateCancer
A Great Day One of #IUCS25 Great Presentation by Dr. Sara Rebuzzi 🇮🇹
⏸️ Treatment Breaks in #KidneyCancer – Key Takeaways
✅ Feasible in selected patients, with potential for long-term disease control
✅ Reduced toxicity burden vs continuous therapy
📊 Stronger evidence with ICI than TKI
Day2⃣of #IUCS25 🇬🇧Portsmouth
Dr. Enrique Grande 🇪🇸 discusses “Geting more patient the right 1st line in Bladder Cancer.”
👉 improving patient selection, refining dosing strategies, and developing predictive tools are key to making sure more patients receive and benefit the right first-line tx
Day2⃣of #IUCS25 🇬🇧Portsmouth
Dr. Petros Grivas🇺🇸 discusses “How Perioperative Treatment is Evolving in Bladder Cancer.”
📌 The perioperative space in MIBC is rapidly transforming—biomarkers, immunotherapy, ADCs, and combinations are reshaping the standard of care.
The OncoAlert WEEKLY RoundUp 🚨
Covering the TOP of the week Aug 28-Sept 4, 2025
REGISTER HERE👉 www.OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa...
youtu.be/maThWN36_sc
@elisaagostinetto.bsky.social @elisabettabonzano.bsky.social @fumikochino.bsky.social @agerikssonmd.bsky.social
Experience the 2025 International Symposium of Gastrointestinal Oncology (ISGIO) LIVE in Austin Tx or Streamed ONLINE ! 👉 FREE HCP Registration (USE CODE: ONCOALERT )🚨
buff.ly/KVngjav
Join leading experts for two days of case-based learning, interactive panels, and cutting-edge updates in GI
You're invited to watch the Post-ASCO 2025 Lung Cancer Highlights webinar by @VJOncology 🫁 Watch Here 👉 bit.ly/4o14fdK
Featuring expert presentations and in-depth discussions on key abstracts in #Lungcancer presented at ASCO 2025.
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week August 15-21, 2025
youtu.be/4DAcGeK-Qac
REGISTER at ww.OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa...
Development of a Health-related Quality of Life Questionnaire for Patients with Metastatic or Localized Renal Cell Carcinoma
www.sciencedirect.com/science/arti...
This international four-phase study (2022–2024) sought to modernize health-related quality of life (HRQOL) assessment tools
Join Our Collaborators at @SpringerIME to explore this new, FREE clinical pathway tool designed to help you detect and target NTRK fusions🧬 & HER2 mutations in #NSCLC 🫁 #LungCancer
CLICK HERE👉https://buff.ly/FeMbJ0r
Anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) in patients with advanced esophageal squamous cell carcinoma: A multicenter, open-label, phase 1b clinical trial
acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
The OncoAlert WEEKLY RoundUp 🚨
Covering the TOP of the week July 18-24, 2025
👉REGISTER at oncoalert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa...
youtu.be/Jy2Wa2yMmMo
@elisaagostinetto.bsky.social
@elisabettabonzano.bsky.social
@icromeattini.bsky.social
@realbowtiedoc.bsky.social
@weoncologists.bsky.social summarizes the @oncoalert.bsky.social round-up 🤠
#SuppOnc dataon #GA the pillar assessment for #olderadults
#GIonc includes #agnostic treatments in #dMMR cancer 🧬
Be sure to not miss an update by signing up 🔗: oncoalert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa...
The OncoAlert🚨Weekly Round Up Covering July 4-10, 2025
www.youtube.com/watch?v=ib45...
👉 REGISTER at www.OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa...
